当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.1.inclusion criteria

inclusion criteria

Patients with anterior neck pain as the chief complaint

1.2.exclusion criteria

Patients with one of the following exclusion criteria

1.3.doctor name

doctor name

熊周怡

2.Baseline
2.1.General information

patient name

胡桂娇

birthday

1965-08-06

gender

female

nation

Han

ABO blood type

unidentified

RH blood type

unidentified

certificate type

identity card

ID number

440221196508063523

place of residence

广东省韶关市武江区

marital status

married

Highest Education Level

junior high school

occupation

worker
/
farmer

medical insurance

Basic medical insurance for urban workers

name of contact

phone

2.2.Medical information
2.2.2.2.2.1、first

content

outpatient

hospital name

外院

register number

date of hospital visiting

2022-08-10

department

内科

current diagnose

颈痛

Consistent with the final diagnosis

no

2.2.2.2.2.2、second

content

emergency

hospital name

粤北人民医院

register number

01123519

date of hospital visiting

2022-10-08

department

急诊

current diagnose

发热

Consistent with the final diagnosis

no

2.2.2.2.2.3、third

content

inpatient

hospital name

粤北人民医院

register number

01123519

就诊日期/住院日期

2022-10-12

department

内分泌科

current diagnose

亚急性甲状腺炎

Consistent with the final diagnosis

yes

2.2.2.2.2.4、fourth

content

hospital name

register number

date of hospital visiting

department

current diagnose

Consistent with the final diagnosis

2.2.2.2.2.5、onset situation

Whether the first visiting

no

onset season

summer

recurrent

no

Time of first attack

2.3.Relevant medication status before treatment
2.2.3.2.3.1、Whether the drug use

whether the drug

2.2.3.2.3.2、drug1

drug name

消炎药

doseage

不详

unit of doseage

administration route

po

Dosing frequency

start date

不详

time of duration(days)

3天

2.2.3.2.3.3、drug2

drug name

退热药

doseage

不详

unit of doseage

administration route

po

Dosing frequency

start date

不详

time of duration(days)

3

2.2.3.2.3.4、drug3

drug name

doseage

unit of doseage

administration route

Dosing frequency

start date

time of duration(days)

2.4.Physical examination

Vital signs and laboratory examination

Yes

date

2022-10-12

2.2.4.2.4.2、system

overall appearance

normal

EENT

normal

head

normal

lung

normal

abdoman

normal

Spinal&limbs

normal

2.2.4.2.4.4、vital signs

height(cm)

162

weight(kg)

53.5

BMI(KG/M2)

20.39

waistline(cm)

body temperature(°C)

36.5

pulse(bpm)

94

heart rate(bpm)

94

breathe(bpm)

20

diastolic pressure(mmHg)

80

systolic pressure(mmHg)

116

2.2.4.2.4.5、thyroid pain

degree

medium

location

both side

time of duration(days)

60

Whether it is the first symptom

yes

2.2.4.2.4.6、fever

time of duration(days)

20

Whether it is the first symptom

no

degree

Moderate fever

2.2.4.2.4.7、cold before onset

yes/no

no

time of duration(days)

Whether it is the first symptom

2.2.4.2.4.8、radiation pain

yes/no

yes

location

head

time of duration(days)

20

Whether it is the first symptom

no

2.2.4.2.4.9、paopitation

yes/no

no

time of duration(days)

Whether it is the first symptom

2.2.4.2.4.10、tremble

yes/no

no

time of duration(days)

Whether it is the first symptom

2.2.4.2.4.11、weight lose

yes/no

yes

time of duration(days)

60

Whether it is the first symptom

no

2.2.4.2.4.12、goiter

yes/no

medium

location

both side

time of duration(days)

60

Whether it is the first symptom

no

2.2.4.2.4.13、thyroid tenderness

yes/no

medium

location

both side

time of duration(days)

60

Whether it is the first symptom

yes

2.5.allergic history

yes/no

allergen

2.6.Relevant Family History

Type of Family Medical History

kinship

2.7.Personal medical history and past history

if has hypertension

if has diabetes

if has coronary heart disease

2.8.laboratory examination
2.2.8.2.8.1、blood routine

WBC

8.88 ×109 /L

NEUT%

80.2 %

LY%

%

MONO%

RBC

×10^12 /L

HGB

g/L

PLT

×10^9 /L

Researcher signature

熊周怡

Date

2022-10 yyyy-mm-dd

2.2.8.2.8.2、Inflammatory biomarkers

ESR(mm/h)

97

C-reaction protein(Mg/ml)

11.78

2.2.8.2.8.3、thyroid function

Thyroid stimulating hormone, TSH

<0.005 uIU/ml

FT3

6.58 pmol/L

FT4

26.91 pmol/L

Anti-TG

273 IU/ml

Anti-TP0

16.5 IU/ml

Diagnosed as

Hyperthyroidism

2.2.8.2.8.4、thyroid antibody

TRAb(IU/L)

<0.25

2.9.影像学检查
2.2.9.2.9.1、thyroid ECT

Thyroid morphology

irregular

Taken technetium function

normal

description

甲状腺肿大,边界不清晰,摄锝功能正常

2.2.9.2.9.2、thyroid B-type ultrasound

thyroid enlargement

isthmus

left lobe width(mm)

22

left lobe thickness

26

right lobe width(mm)

30

right lobe thickness(mm)

27

isthmus thickness(mm)

4.7

echo

Echo weakened

Blood flow situation

normal

decribe

甲状腺内片状回声减低区,考虑甲状腺炎

2.10.FNAC

Based site

pathology results

description

2.11.diagnostic scale

Thyroid tenderness(6 scores)

yes

Firm on palpation(3 scores)

yes

Increased ESR(3 scores)

yes

elevated thyroid hormone level(2 scores)

yes

total score

14

3.SOPs
3.1.Treatment SOP
3.2.
3.3.Data management system
3.4.ADR/ADE management system
4.Research team
4.1.institutions
4.2.researchers
5.Design, Methods
5.1.Calculation of sample size
6.Management for Progress

Whether got the informed consent?

Date of sign the informed consent

xx年xx月xx日